Professor, Internal Medicine, UC, Davis School of Medicine
Oncology
Dr. Sidney A. Scudder, MD
|
|
Give Review
Doctor Sidney A. Scudder, MD works in the field of Oncology. He researched medicine at University of Florida College of Medicine. University of Florida College of Medicine is ranked 43/78 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Sidney A. Scudder, MD is a published physician as well. He has 27 publications published. The latest was: 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. He accepts all Medicare patients.
Publications
- Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.
- Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical Cancer patients.
- Increased incidence of symptomatic venous thrombosis in patients with cervical Carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin.
- The integration of computed tomography and magnetic resonance imaging in treatment planning for gynecologic Cancer.
- Polymorphisms and clinical outcome in recurrent ovarian Cancer treated with cyclophosphamide and bevacizumab.
- An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of Cancer clinical trial costs in California.
- Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian Cancer.
- Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian Cancer: a trial of the California, Chicago, and Princess Marg...
- Endometriosis-related malignancies.
- Primary clear cell adenoCarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report.
- Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian Cancer: a California Cancer Consortium Trial.
- Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal Cancer treated with chemotherapy, radiation, and erythropoeitin.
- Prospective evaluation of Cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
- Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good res...
- 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical Cancer: a Southwest Oncology Group phase II randomized trial.
- Clinicopathologic significance of transitional cell Carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4).
- Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar Cancer.
- DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells.
- High-dose megestrol acetate therapy of ovarian Carcinoma: a phase II study by the Northern California Oncology Group.
- Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell Carcinoma: a phase I study.
- A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2.
- Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenoCarcinoma: a phase II study of the Southwest Oncology Group.
- Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian Cancer in first remission or chem...
- Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous Cancer of the vulva.
- Chemoradiation for primary invasive squamous Carcinoma of the vagina.
- Tirapazamine plus cisplatin in advanced or recurrent Carcinoma of the uterine cervix: a Southwest Oncology Group study.
Schools
Univ Of Fl Coll Of Med
Barnes Jewish Hospital
Stanford University
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Washington University - Barnes-Jewish Hospital -
University of Florida College of Medicine
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1275514648 | |
| NPPES Provider LastName | SCUDDER | |
| NPPES Provider FirstName | SIDNEY | |
| NPPES Provider ZIPCode | 958172229 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 514.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 73.0 | |
| Percent Opioid Claims | 14.2 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275514648 |
| Last Name Of The Provider | SCUDDER |
| First Name Of The Provider | SIDNEY |
| View All |
Similar Doctors
|
Dr. Robert E. Quadro, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nitin Rohatgi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Kaesberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jocelyn Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hanh H. La, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gilbert L. Mandell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashok P. Pai, MD
This Doctor is OpenDoctor Recommended.
|